Clinical Trial Update: The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating imipramine for refractory functional dyspepsia, reporting efficacy outcomes from a pivotal study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Imipramine (imipramine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Functional Gastrointestinal Disorder | Phase 3 | Status: COMPLETED